Abhilasha Singh

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Low Density Lipoprotein

Extracellular Matrix

Cardiovascular Events

Top Venues

Oxidative medicine and cellular longevity

Circulation research

University of Houston

Dayalbagh Educational Institute (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Houston Mar 16 2020

United States

Post-Doctoral Fellow :: Pharmacy and Pharmaceutical Sciences

Weill Cornell Medicine Mar 01 2019 - Mar 15 2020

United States

Post Doctoral Fellow :: Burke Medical Research Institute

University of Madras

India

Senior Research Fellow :: BIOCHEMISTRY

Indian Institute of Technology Madras

India

Project Associate :: BIOTECHNOLOGY

Education History

Dayalbagh Educational Institute

India

BSC :: SCIENCE

Publications

Jason D Roh, Joseph A Hill, Abhilasha Singh, María Valero-Muñoz, Flora Sam
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models. Circulation research 130 (12) (2022)
Prema Velusamy, Thangarajeswari Mohan, Divya Bhavani Ravi, Kishore Kumar S Narasimhan, Ashokkumar Srinivasan, Lakshmi Narasimhan Chakrapani, Abhilasha Singh, Saradhadevi Varadharaj, Periandavan Kalaiselvi
Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis. Oxidative medicine and cellular longevity 2020 (2020)
Abhilasha Singh, Ashok Kumar Srinivasan, Lakshmi Narasimhan Chakrapani, Periandavan Kalaiselvi
LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline. Oxidative medicine and cellular longevity 2019 (2019)